Most MG patients have anti-AChR antibodies, and antibodies against MuSK (muscle-specific receptor tyrosine kinase) and LRP4 (low-density lipoprotein receptor-related protein 4) have been found to be involved in the pathogenesis of MG. Here, LRP4 is linked to myasthenia gravis.